Phibro Animal Health

Phibro Animal Health is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock.[6][7] The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived.[8] The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific.[6] It is incorporated in Delaware.[9]

Phibro Animal Health Corporation
TypePublic
Nasdaq: PAHC
S&P 600 Component
IndustryAnimal health and nutrition
HeadquartersTeaneck, New Jersey, US
Key people
Jack Bendham (Chairman), Larry Miller (COO)[1][2]
RevenueIncrease US$833 million (2021)[3]
Number of employees
1,400[4][5]
Websitewww.pahc.com

History

The company was founded in 1946 as Phillip Brothers Chemicals, Inc.[10][11]

In 1974, it acquired Koffolk, an animal nutrition company based in Israel.[10]

In 2000, Pfizer sold its medicated feed additives business to Phibro Animal Health[12][10]

In 2003, the company changed its name from Phillip Brothers Chemicals to Phibro Animal Health.[13][10]

In 2009, the company acquired Baltzell US mineral nutrition business and ABIC Laboratories, a vaccine maker from Israel.[14][10]

In 2014, Phibro Animal Health held an initial public offering and became listed on the Nasdaq.[15][16]

In 2018, the company established a biotech facility in Sligo, Ireland producing animal health vaccines. It became the company's first manufacturing plant in Europe.[4][5]

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.